Clinical Trial

Adsorption of Cell-free Diphtheria and Tetanus (Three-component) Combined With Vaccine Phase III Clinical Trial

Name: Adsorption of Cell-free Diphtheria and Tetanus (Three-component) Combined With Vaccine Phase III Clinical Trial — clinical trial record (NCT07112144)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting Phase 3

View on ClinicalTrials.gov →

Summary

The immunogenicity and safety of the adsorption of cell-free diphtheria and tetanus (three-component) combined vaccine were evaluated at 2 months, 4 months and 6 months.

Trial Details

NCT Number	NCT07112144
Lead Sponsor	Changchun BCHT Biotechnology Co. Collaborators: Yunnan Provincial Center for Disease Control and Prevention, Shaanxi Provincial Center for Disease Control and Prevention, Guizhou Provincial Center for Disease Control and Prevention, Shandong Provincial Center for Disease Control and Prevention
Conditions	Prevent Whooping Cough, Prevent Diphtheria, Prevent Tetanus
Enrollment	1,650 participants
Start Date	2025-06-13
Primary Completion	2032-06 (estimated)
Study Completion	2032-06 (estimated)
Updated on ClinicalTrials.gov	2025-08-08